China To Step Up Supervision Of Human Organ Transplants; Enforce Ban On Foreigners Receiving Transplants
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - China's Ministry Of Health is set to extensively review hospitals already approved to provide human organ transplants nationwide, and will bar any other hospitals from facilitating transplants in the future, according to a report published on the ministry's official Web site
You may also be interested in...
China’s MOH Sets Up Three New Departments To Oversee Food And Drugs
To tighten hospital supervision, food and drug safety, China's Ministry of Health has set up three departments for overseeing health care services, drug policy and the basic medicine system, as well as food safety coordination and hygiene. This follows responsibility changes between MOH and China's State FDA (PharmAsia News, Sep. 8, 2008). Under the framework, the new departments will (1) monitor health care institutions' services and promote public hospital management system reform; (2) establish and implement the national basic medicine system, as well as draw up the country's drug policy; and (3) draft standards for food safety and investigate major food safety incidents. Health authorities at the local level may decide on their own whether to undertake the corresponding changes. (Click here for more - Chinese Language)
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).
PharmAsia News Business Bulletin
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).